CDNA insider buying and SEC filings, explained
CareDx, Inc. · CIK 1217234
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.2M
Planned sales (10b5-1)
$10.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 5, 2026 | Planned (10b5-1) | Jeffrey Adam Novack (Secretary and General Counsel) sold 2,688 shares at about $46.26 ($124K), marked as a 10b5-1 plan trade. Holdings down 2% to 106,075 shares. | SEC filing Filed Aug 6, 2026 |
| Aug 5, 2026 | Sale | George Bickerstaff (Director) sold 20,000 shares at about $46.29 ($926K). Holdings down 13% to 134,061 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 6, 2026 |
| Aug 4, 2026 | Sale | Michael Goldberg (Director) sold 44,700 shares at $47.06 ($2.1M). Holdings down 42% to 61,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 6, 2026 |
| Aug 4, 2026 | Planned (10b5-1) | Christine Cournoyer (Director) sold 16,000 shares at about $46.94 ($751K), marked as a 10b5-1 plan trade. Holdings down 27% to 42,943 shares. | SEC filing Filed Aug 6, 2026 |
| Jul 16, 2026 | Planned (10b5-1) | Hannah Valantine (Director) sold 28,779 shares at about $36.14 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 44% to 36,686 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 16, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 118,000 shares at about $37.78 ($4.5M), marked as a 10b5-1 plan trade. Holdings down 15% to 653,448 shares. | SEC filing Filed Jul 17, 2026 |
| Jun 26–29, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 40,000 shares between Jun 26 and Jun 29 at about $29.24 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 6% to 661,959 shares. | SEC filing Filed Jun 30, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 17,683 shares at about $24.03 ($425K), marked as a 10b5-1 plan trade. Holdings down 3% to 631,959 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Hannah Valantine (Director) sold 12,103 shares at about $23.11 ($280K), marked as a 10b5-1 plan trade. Holdings down 25% to 36,686 shares. | SEC filing Filed Jun 16, 2026 |
| Jun 11, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 21,998 shares at about $24.02 ($528K), marked as a 10b5-1 plan trade. Holdings down 3% to 649,642 shares. | SEC filing Filed Jun 15, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 4,835 shares at about $24.00 ($116K), marked as a 10b5-1 plan trade. Holdings down 1% to 671,640 shares. | SEC filing Filed Jun 8, 2026 |
| May 14–15, 2026 | Sale | Arthur A. Torres (Director) sold 10,570 shares between May 14 and May 15 at about $20.31 ($215K). Holdings down 21% to 38,665 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| May 5, 2026 | Planned (10b5-1) | Jeffrey Adam Novack (Secretary and General Counsel) sold 2,688 shares at about $20.68 ($56K), marked as a 10b5-1 plan trade. Holdings down 2% to 113,924 shares. | SEC filing Filed May 6, 2026 |
| Apr 16, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 10,282 shares at $21.12 ($217K), marked as a 10b5-1 plan trade. Holdings down 1% to 676,475 shares. | SEC filing Filed Apr 20, 2026 |
| Feb 3, 2026 | Planned (10b5-1) | Jeffrey Adam Novack (Secretary and General Counsel) sold 4,441 shares at $20.56 ($91K), marked as a 10b5-1 plan trade. Holdings down 3% to 125,364 shares. | SEC filing Filed Feb 4, 2026 |
| Jan 21–22, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 19,480 shares between Jan 21 and Jan 22 at about $21.16 ($412K), marked as a 10b5-1 plan trade. Holdings down 3% to 597,405 shares. | SEC filing Filed Jan 23, 2026 |
| Jan 15, 2026 | Planned (10b5-1) | John Walter Hanna JR (CEO and Director) sold 10,156 shares at about $21.05 ($214K), marked as a 10b5-1 plan trade. Holdings down 2% to 616,885 shares. | SEC filing Filed Jan 20, 2026 |
| Dec 4, 2025 | Planned (10b5-1) | Jeffrey Adam Novack (Secretary and General Counsel) sold 7,293 shares at about $19.17 ($140K), marked as a 10b5-1 plan trade. Holdings down 7% to 97,925 shares. | SEC filing Filed Dec 5, 2025 |
| Nov 7, 2025 | Planned (10b5-1) | Jeffrey Adam Novack (Secretary and General Counsel) sold 2,688 shares at $15.52 ($42K), marked as a 10b5-1 plan trade. Holdings down 2% to 105,218 shares. | SEC filing Filed Nov 10, 2025 |
42 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CDNA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.